Patent granted for toxoplasmosis research

  • April 29, 2014
Patent granted for toxoplasmosis research

Bo Shiun Lai and his research colleagues have been granted a patent by the US authorities to develop a treatement for toxoplasmosis.

A Gates Cambridge Scholar and his team have been granted a patent by the US authorities to develop a treatement for toxoplasmosis.

Bo Shiun Lai [2013] and colleagues submitted a patent application around a year and a half ago when Bo Shiun was still doing his undergraduate degree at the Univesity of Chicago and have just been awarded a US patent. He is continuing his research at the University of Cambridge, where he is doing a PhD in Pathology.

Toxoplasmosis is a parasite which is hosted by two billion people worldwide, mostly without any visible symptoms. However, if their immune system is suppressed, for instance, if they are newborn or have HIV, it can cause serious problems. In newborns it can cause ocular impairment or brain defects and brain inflammation caused by toxoplasmosis is a major cause of death in people with HIV. It is relatively rare among newborns and has been considered a neglected disease, but since 9/11, it has been classified as a bioterror agent by the US National Institute of Allergy and Infectious Diseases (NIAID) which led to increased interest until the financial meltdown.

Toxoplasmosis takes two forms: active and dormant. When it is dormant the parasite wraps itself in a thick layer of lipid which makes it impervious to all drug treatment and impossible to eradicate. Bo Shiun’s research into toxoplasmosis focuses on two main challenges: how to deliver drugs across the lipid barrier and what specific molecular pathways to inhibit. As toxoplasmosis mainly resides in the eyes and brain, treatment has to cross the ocular membrane or enter the brain.

His work prior to arriving at Cambridge in 2013 was focused on the first challenge, attempting to create a molecule that could have an inhibitory effect on the parasite and deliver medication across multiple membranes. At Cambridge, he has been targeting the second challenge – how to switch the parasite from dormant to active mode, making it susceptible to existing treatment, or shut off essential pathways, killing the parasite effectively.

He says: “This approach is a breakthrough because it allows us to deliver drugs across numerous layers of obstacles, arrive at the intended target (ideally essential for parasite survival or replication), and abrogate parasite growth. The patent is promising for delivering inhibitory molecules into both active and dormant parasites.”

The researchers found that their original model had a small therapeutic range in which it could be both effective and non toxic. They believe the toxicity originates from the transductive peptides which help deliver the drugs across the lipid barrier to the parasite and have been trying to reduce it. So far they have expanded the therapeutic range by about four times. Bo Shiun says: “This means we can increase the dosage dramatically without observable toxicity.”

Bo Shiun’s work has seen him nominated for the Cozzarelli Prize, a national award for scientific excellence in a particular scientific discipline and three of his articles were accepted for publication in peer review journals before he finished his undergraduate degree.

Latest News

Rethinking feminist approaches to gender-based violence

Ilaria Michelis [2019] was completely surprised when, earlier this year, she was awarded this year’s Journal of Gender Studies Janet Blackman Prize. The Prize celebrates scholarship on international feminist movements and trade unions/women in work.  It was awarded for an article she published the year before in the Journal of Gender Studies based on an issue […]

Scholars scoop three social impact awards

Three Gates Cambridge Scholars have been recognised with awards from the Vice Chancellor of the University of Cambridge. The 15 Social Impact Awards in six categories were launched for the first time by Cambridge Hub in 2018-19, to celebrate students who have shown exceptional achievement in, and commitment to, creating positive social change. Since then, […]

Report highlights fatal health risk of climate change in Europe

Climate change is here, in Europe, and it kills. This is the warning of 69 contributors of the 2024 Europe report of the Lancet Countdown, published today in the Lancet Public Health and led by Gates Cambridge Scholar Kim Van Daalen [2018]. Tracking the links between climate change and health across the region, the new […]

Tracing the role of transposable elements in disease

What causes genetic disease? Rebecca Berrens’ research focuses on transposable elements or transposons, pieces of DNA formed as a result of ancient viruses that inserted into our genome. These can damage genes when they are active in the early stages of human development because they are able to move about the genome.  This can result […]